Information Library

Results for: Clinical and marketing materials - Get to market faster - Consulting

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Quintiles Addresses Key Considerations for Successful Biosimilar Development

    Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.

  • Commercial – Identify, Promote and Prove Treatment Value

    Brochure — April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • Orphan Drugs in the U.S.

    Presentation — June 24, 2009
    Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009(International Society for Pharmacoeconomics and Outcomes Research) on “Orphan Drugs' Market Access in the U.S.”

  • A Testimonial About Quintiles Portugal

    Testimonial — March 30, 2009
    A testimonial about a commercial solution.

  • James C. Kirk

    Hear from the Experts — March 25, 2009
    Jim joined Eidetics in 1988 from senior management positions in consumer and industrial product marketing, strategy, and development positions at Ocean Spray Cranberries and Gillette Company. Previously at Ocean Spray, Jim successfully spearheaded the company’s new Ingredient Division.

  • John Doyle, Dr.P.H., MPH

    Hear from the Experts — March 25, 2009
    John Doyle, Dr.P.H., MPH, is Senior Vice President and Practice Leader, Commercial and Market Access Strategy, Consulting at Quintiles.

Page 1 of 1 (6 results)

Subscribe to Email Based on Your Interests

Set preferences